MAZE - Latest News

Maze Therapeutics, Inc. (MAZE), operates in Healthcare / Biotechnology, trades on NASDAQ.

Market capitalization stands near $1.48B. Beta to the broader market is 2.15.

The article list below shows the most recent MAZE headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent MAZE Headlines

Head to Head Survey: Maze Therapeutics (NASDAQ:MAZE) and Cytokinetics (NASDAQ:CYTK)

defenseworld.net - Oct 13, 2026

Maze Therapeutics (NASDAQ: MAZE - Get Free Report) and Cytokinetics (NASDAQ: CYTK - Get Free Report) are both healthcare companies, but which is the s

Maze Therapeutics to Present Data from MZE829 and MZE782 Programs at ASN Kidney Week 2026

globenewswire.com - Oct 6, 2026

Oral presentation will highlight previously reported Phase 2 HORIZON data for MZE829 in patients with APOL1-mediated kidney disease Two poster present

3 Small-Cap Stocks With Catalysts That Could Put Them in the Spotlight

marketbeat.com - Oct 5, 2026

Small-cap companies are accustomed to living in the shadow of mega-cap tech firms, but there are signs that the market backdrop could be changing for

Maze Therapeutics, Inc. (NASDAQ:MAZE) Stock Has Consensus Price Target of $63.40

defenseworld.net - Oct 1, 2026

Maze Therapeutics, Inc. (NASDAQ: MAZE - Get Free Report) has earned a consensus recommendation of "Buy" from the thirteen brokerages that are coverin

Maze Therapeutics (NASDAQ:MAZE) Shares Climb 4.5% – Still a Buy?

defenseworld.net - Sep 30, 2026

Maze Therapeutics, Inc. (NASDAQ: MAZE - Get Free Report)'s stock price shot up 4.

How News Affects MAZE Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track MAZE's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked MAZE news questions

What is the latest MAZE news headline?

The most recent MAZE headline (Oct 13, 2026) is "Head to Head Survey: Maze Therapeutics (NASDAQ:MAZE) and Cytokinetics (NASDAQ:CYTK)". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.

How fresh is the MAZE news on this page?

News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.

What MAZE news moves options pricing?

Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.

How can I track unusual MAZE options activity related to news?

Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.